DE60139554D1 - Probiotika zur primären prävention atopischer erkrankungen - Google Patents
Probiotika zur primären prävention atopischer erkrankungenInfo
- Publication number
- DE60139554D1 DE60139554D1 DE60139554T DE60139554T DE60139554D1 DE 60139554 D1 DE60139554 D1 DE 60139554D1 DE 60139554 T DE60139554 T DE 60139554T DE 60139554 T DE60139554 T DE 60139554T DE 60139554 D1 DE60139554 D1 DE 60139554D1
- Authority
- DE
- Germany
- Prior art keywords
- atopic diseases
- probiotics
- primary prevention
- atopic
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y10S435/856—Lactobacillus casei
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20001460A FI110668B (fi) | 2000-06-20 | 2000-06-20 | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn |
PCT/FI2001/000588 WO2001097822A1 (en) | 2000-06-20 | 2001-06-20 | Probiotics in primary prevention of atopic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60139554D1 true DE60139554D1 (de) | 2009-09-24 |
Family
ID=8558595
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60139554T Expired - Lifetime DE60139554D1 (de) | 2000-06-20 | 2001-06-20 | Probiotika zur primären prävention atopischer erkrankungen |
DE01951716T Pending DE01951716T1 (de) | 2000-06-20 | 2001-06-20 | Probiotika zur primären prävention atopischer erkrankungen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE01951716T Pending DE01951716T1 (de) | 2000-06-20 | 2001-06-20 | Probiotika zur primären prävention atopischer erkrankungen |
Country Status (9)
Country | Link |
---|---|
US (2) | US7112322B2 (de) |
EP (3) | EP1296694B1 (de) |
AT (1) | ATE439138T1 (de) |
AU (1) | AU784921B2 (de) |
DE (2) | DE60139554D1 (de) |
ES (3) | ES2329549T3 (de) |
FI (1) | FI110668B (de) |
PT (2) | PT1296694E (de) |
WO (1) | WO2001097822A1 (de) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1364586A1 (de) * | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotika und Oraltoleranz |
JP4212838B2 (ja) * | 2002-06-26 | 2009-01-21 | カルピス株式会社 | 抗アレルギー剤 |
US20090257993A1 (en) | 2003-12-17 | 2009-10-15 | M Rabet Laura | Lactic Acid Producing Bacteria and Lung Function |
US7955834B2 (en) | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1731137A1 (de) * | 2005-06-08 | 2006-12-13 | Nestec S.A. | Kosmetische oder dermatologische Zusammensetzung gegen trockene und/oder empfindliche Haut |
MX2007004135A (es) * | 2004-10-04 | 2007-06-15 | Oreal | Composicion cosmetica y/o dermatologica para pieles sensibles. |
FR2876029B1 (fr) * | 2004-10-04 | 2008-11-14 | Oreal | Composition cosmetique et/ou dermatologique pour peaux sensibles. |
EP1642570A1 (de) | 2004-10-04 | 2006-04-05 | L'oreal | Kosmetische oder dermatologische Zusammensetzung gegen trockene und/oder empfindliche Haut |
ITMI20042189A1 (it) | 2004-11-16 | 2005-02-16 | Anidral Srl | Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale |
RU2270248C1 (ru) * | 2004-12-31 | 2006-02-20 | Открытое акционерное общество "Лианозовский молочный комбинат" | Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств |
US7303745B2 (en) | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
EP2264164A1 (de) | 2005-05-11 | 2010-12-22 | Chr. Hansen A/S | Antibiotikasensitive Milchsäurebakterienstämme |
JP2009067679A (ja) * | 2005-12-27 | 2009-04-02 | Univ Of Tokushima | 抗ヒスタミン作用を有する医薬 |
CA2883256A1 (en) | 2006-03-10 | 2007-09-20 | N.V. Nutricia | Use of non-digestible saccharides for strengthening the immune system |
EP2084276A1 (de) | 2006-11-15 | 2009-08-05 | Chr. Hansen A/S | Neue tetracyclin-empfindliche bifidobakterien-stämme |
US20100092429A1 (en) | 2006-12-11 | 2010-04-15 | Danisco A/S | Composition |
KR20100014523A (ko) * | 2007-02-22 | 2010-02-10 | 위르겐 슈레첸메이르 | 인간의 알레르기 반응을 예방, 억제 또는 제거하는 프로바이오틱 그램-양성 박테리아 |
EP1974743A1 (de) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotika zur Verbesserung der Darm-Biozönose |
CN101273737B (zh) * | 2007-03-28 | 2011-08-24 | 哈尔滨正方科技有限公司 | 一种在常温下保持高活菌数的发酵乳饮料的制备方法 |
EP1974734A1 (de) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotika zur Minderung des Risikos von Fettleibigkeit |
US20090007924A1 (en) * | 2007-04-30 | 2009-01-08 | Iliff Edwin C | Arbiter system and method of computerized medical diagnosis and advice |
FR2920305B1 (fr) | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
FR2920304B1 (fr) | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
EP2668854B1 (de) | 2008-03-28 | 2015-07-01 | Nestec S.A. | Probiotika zur Verwendung für schwangere weibliche Säuger zur Steigerung der Immunität der Jungen |
US20110053889A1 (en) * | 2008-09-02 | 2011-03-03 | Joanne Szabo | Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function |
FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
WO2011044516A2 (en) * | 2009-10-09 | 2011-04-14 | Prothera, Inc. | Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease |
CN102269858A (zh) | 2010-06-02 | 2011-12-07 | 北京智朗芯光科技有限公司 | 自动聚焦系统和自动聚焦方法 |
KR101850165B1 (ko) * | 2010-06-30 | 2018-04-18 | 네스텍 소시에테아노님 | 피부 색소침착 조절용 식품 보충제에 있어서 카프타르산 및 락틱 박테리아의 용도 |
US9539269B2 (en) | 2010-12-31 | 2017-01-10 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
SG191394A1 (en) | 2010-12-31 | 2013-08-30 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
EE05750B1 (et) | 2011-02-25 | 2015-06-15 | OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine |
EP2510932A1 (de) | 2011-04-15 | 2012-10-17 | Nestec S.A. | Lactobacillus paracasei NCC2461 (ST11) zur Verwendung mittels perinataler maternaler Verabreichung zur Verringerung und Vorbeugung von Allergien bei den Nachkommen |
WO2012177556A2 (en) | 2011-06-20 | 2012-12-27 | H.J. Heinz Company | Probiotic compositions and methods |
ES2657744T3 (es) | 2011-07-22 | 2018-03-06 | Abbott Laboratories | Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal |
EP2750523A1 (de) | 2011-08-29 | 2014-07-09 | Abbott Laboratories | Galactooligosaccharide aus der muttermilch zur prävention von läsionen und/oder förderung der heilung des magen-darm-traktes |
EP2617296A1 (de) * | 2012-01-19 | 2013-07-24 | Nestec S.A. | Zusammensetzung mit spezifischen Lactobacillus-helveticus-Stämmen und Verringerung von Lebensmittel- und/oder Atemwegsallergiesymptomen |
EP2836224A4 (de) | 2012-02-29 | 2015-12-16 | Ethicon Endo Surgery Inc | Zusammensetzungen von biozönose und zugehörige verfahren |
DK2861242T3 (en) | 2012-06-18 | 2018-10-29 | Heinz Co Brands H J Llc | GLUTEN RELATED DISORDERS |
WO2014052438A1 (en) | 2012-09-25 | 2014-04-03 | Regents Of The University Of Minnesota | Methods for making and using antimicrobial peptides |
EP2994150B1 (de) | 2013-05-10 | 2019-03-06 | H.J. Heinz Company Brands Llc | Probiotika und verfahren zur verwendung |
US20150064304A1 (en) * | 2013-09-03 | 2015-03-05 | Mario Medri | Probiotic lozenge, method of making same, and uses thereof |
WO2015071131A1 (en) * | 2013-11-15 | 2015-05-21 | Nestec S.A. | Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section |
WO2015090349A1 (en) | 2013-12-16 | 2015-06-25 | Nestec S.A. | Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants |
EP2886660A1 (de) * | 2013-12-20 | 2015-06-24 | Rigas Tehniska universitate | In-situ-Fluoreszenzhybridisierungsverfahren zur Identifizierung eines Mikroorganismus |
JP6868562B2 (ja) | 2014-10-31 | 2021-05-19 | ペンデュラム セラピューティクス, インコーポレイテッド | 障害の微生物的処置および診断に関する方法および組成物 |
WO2016149687A1 (en) * | 2015-03-18 | 2016-09-22 | Whole Biome, Inc. | Methods and compositions relating to microbial treatment and diagnosis of skin disorders |
CA2950839C (en) * | 2016-01-30 | 2023-09-12 | Cooper Technologies Company | Equipment rack and components thereof |
WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
EP3897678A1 (de) * | 2018-12-21 | 2021-10-27 | Société des Produits Nestlé S.A. | Probiotische kombination zur behandlung von allergischen erkrankungen |
WO2021138599A1 (en) * | 2020-01-03 | 2021-07-08 | Forte Subsidiary, Inc. | Cosmetic compositions |
EP4251183A1 (de) * | 2020-11-24 | 2023-10-04 | Johnson & Johnson Consumer Inc. | Verfahren zur prävention, verzögerung oder linderung von atopischen erkrankungen |
WO2024042229A1 (en) | 2022-08-25 | 2024-02-29 | Chr. Hansen A/S | Bifidobacterium strains with improved stability |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591446A (en) * | 1989-04-04 | 1997-01-07 | Beiersdorf, A.G. | Methods and agents for the prophylaxis of atopy |
US5246591A (en) * | 1990-07-13 | 1993-09-21 | Pact, Incorporated | Separation of metal ions on an anion exchange resin by chromatographic elution |
BE1009359A7 (fr) * | 1995-05-19 | 1997-02-04 | Univ Bruxelles | Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique. |
FI104465B (fi) | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
EP0904784A1 (de) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotisches Ernährungspräparat |
GB9808579D0 (en) * | 1998-04-22 | 1998-06-24 | Novartis Nutrition Ag | Improvements in or relating to organic compounds |
JP4010062B2 (ja) * | 1998-09-02 | 2007-11-21 | 医療法人社団青藍会 | アトピー性皮膚炎を防ぐ保健食品 |
JP2000086524A (ja) | 1998-09-05 | 2000-03-28 | Shadan Seirankai | 生きた腸内細菌を含有する抗アレルギー剤 |
AUPQ415899A0 (en) * | 1999-11-19 | 1999-12-16 | Vasse Research Institute Pty Ltd | Compositions for and methods of treatment of allergic diseases |
-
2000
- 2000-06-20 FI FI20001460A patent/FI110668B/fi active
-
2001
- 2001-06-20 EP EP01951716A patent/EP1296694B1/de not_active Expired - Lifetime
- 2001-06-20 ES ES01951716T patent/ES2329549T3/es not_active Expired - Lifetime
- 2001-06-20 WO PCT/FI2001/000588 patent/WO2001097822A1/en active Application Filing
- 2001-06-20 AU AU72572/01A patent/AU784921B2/en not_active Expired
- 2001-06-20 DE DE60139554T patent/DE60139554D1/de not_active Expired - Lifetime
- 2001-06-20 AT AT01951716T patent/ATE439138T1/de not_active IP Right Cessation
- 2001-06-20 EP EP09164285.0A patent/EP2206507B1/de not_active Expired - Lifetime
- 2001-06-20 EP EP09164284.3A patent/EP2201955B1/de not_active Expired - Lifetime
- 2001-06-20 PT PT01951716T patent/PT1296694E/pt unknown
- 2001-06-20 ES ES09164285T patent/ES2721848T3/es not_active Expired - Lifetime
- 2001-06-20 DE DE01951716T patent/DE01951716T1/de active Pending
- 2001-06-20 ES ES09164284T patent/ES2754797T3/es not_active Expired - Lifetime
- 2001-06-20 PT PT91642843T patent/PT2201955T/pt unknown
- 2001-06-20 US US10/311,706 patent/US7112322B2/en not_active Expired - Lifetime
-
2005
- 2005-09-14 US US11/225,204 patent/US7988960B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2001097822A1 (en) | 2001-12-27 |
EP1296694B1 (de) | 2009-08-12 |
ATE439138T1 (de) | 2009-08-15 |
EP2201955A1 (de) | 2010-06-30 |
US20030180272A1 (en) | 2003-09-25 |
AU7257201A (en) | 2002-01-02 |
US7988960B2 (en) | 2011-08-02 |
US7112322B2 (en) | 2006-09-26 |
PT2201955T (pt) | 2019-11-25 |
FI20001460A (fi) | 2001-12-21 |
EP2206507A1 (de) | 2010-07-14 |
AU784921B2 (en) | 2006-07-27 |
ES2754797T3 (es) | 2020-04-20 |
US20060013806A1 (en) | 2006-01-19 |
PT1296694E (pt) | 2009-10-28 |
EP1296694A1 (de) | 2003-04-02 |
FI110668B (fi) | 2003-03-14 |
EP2201955B1 (de) | 2019-08-14 |
ES2329549T3 (es) | 2009-11-27 |
EP2206507B1 (de) | 2019-03-13 |
ES2721848T3 (es) | 2019-08-05 |
DE01951716T1 (de) | 2005-06-23 |
FI20001460A0 (fi) | 2000-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE439138T1 (de) | Probiotika zur primären prävention atopischer erkrankungen | |
ATE302265T1 (de) | Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon | |
ATE290391T1 (de) | Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen | |
ATE534396T1 (de) | Probiotische mikroorganismen zur verbesserung der muskulären funktion | |
ATE421256T1 (de) | Probiotische zusammensetzung | |
DE60226254D1 (de) | Milchsäureproduzierende bakterien zur verwendung als probiotische organismen in der menschlichen scheide | |
HUP0303728A2 (hu) | Tápanyagkészítmény | |
ATE551063T1 (de) | Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen | |
DE69930944D1 (de) | Bacillus coagulans-zusammensetzung und deren verwendung | |
BR0116349A (pt) | Compostos probióticos derivados da cepa ke01 de lactobacillus casei | |
ATE372124T1 (de) | Zusammensetzung und verfahren zur perkutanen superoxygenierung | |
NO20050411L (no) | Antiallergisk middel, anvendelse derav for reduksjon av allergi og fremgangsmate for reduksjon av allergi | |
HK1111883A1 (en) | Use of a composition for preventing or treating respiratory infections and acute otitis media in infants | |
ATE464045T1 (de) | Zusammensetzung aus milchsäure und lactoferrin | |
BR0015698A (pt) | Composições e métodos para tratamento de doenças alérgicas | |
ATE439851T1 (de) | Verwendung probiotischer bakterien zur behandlung von infektionen | |
WO2003039260A3 (en) | PROBIOTIC COMPOSITIONS | |
IL158738A0 (en) | Novel use of 2-phenyl-substituted imidazotriazinones | |
AL-Saeedi et al. | Bacteriocin from Streptococcus salivarius optimized statistically by response surface methodology active against different clinical oral pathogenic Streptococci | |
DE69927930D1 (de) | Zusammensetzung geeignet als Nahrungsmittelzusatz und zur Anwendung bei Darmerkrankungen sowie bei veränderter Darmflora | |
EE200300220A (et) | Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod | |
ATE454899T1 (de) | Leptin zur behandlung des respiratory-distress- syndroms und verminderter lungen surfactant- produktion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent |